A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

A new study published in JAMA Dermatology reveals that people with cutaneous lupus are 72 per cent more likely to develop ...

Prophylactic valaciclovir was effective and prevented herpes zoster in patients with systemic lupus erythematosus receiving ...

Controlling cardiovascular risk factors and maintaining long-term disease remission mitigated the increased risk for ...

Results showed that systemic lupus carries the greatest risk for heart health, more than doubling a person’s risk of heart ...

New research reveals how social determinants of health significantly affect lupus treatment outcomes in Black patients, with ...

Patients with cutaneous lupus erythematosus may be at an increased risk for atherosclerotic cardiovascular disease, even more ...